Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses.

Author: DulaiParambir S, FumeryMathurin, MuradMohammad Hassan, NguyenNghia H, ProkopLarry J, SandbornWilliam J, SinghSiddharth

Paper Details 
Original Abstract of the Article :
BACKGROUND: The majority of patients with ulcerative colitis have mildly to moderately active disease. To inform the management of patients with left-sided or extensive mildly to moderately active ulcerative colitis, we assessed the comparative efficacy and tolerability of different therapies. METH...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/30122356

データ提供:米国国立医学図書館(NLM)

Navigating Ulcerative Colitis: A Comparative Analysis of Treatments

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that can significantly impact quality of life. This study delves into the effectiveness and tolerability of different pharmacological agents for managing mildly to moderately active UC. The researchers conducted a comprehensive systematic review and network meta-analysis, comparing various treatment options to identify the most effective and well-tolerated approaches for UC.

Optimizing Ulcerative Colitis Treatment: A Multifaceted Approach

The study found that combined oral and rectal mesalazine therapy, as well as high-dose mesalazine, were more effective than standard-dose mesalazine for inducing remission in patients with mildly to moderately active UC. However, all treatment options were superior to placebo for maintaining remission. This highlights the importance of individualized treatment plans tailored to the specific needs of each patient.

Managing Ulcerative Colitis: A Holistic Perspective

UC is a complex condition, and finding the most effective treatment involves a collaborative approach between patient and healthcare provider. It's crucial to discuss your symptoms, treatment options, and potential side effects openly with your doctor. Remember, there is no one-size-fits-all solution for UC, and a personalized approach is key to achieving optimal symptom management and overall well-being.

Dr. Camel's Conclusion

This study provides valuable insights into the multifaceted landscape of UC treatment, suggesting that combined oral and rectal mesalazine therapy, as well as high-dose mesalazine, can be effective options for inducing remission. However, the most effective treatment for each individual will vary based on their specific needs and circumstances. As always, open communication with your doctor is crucial for navigating UC and finding the best possible path to symptom management and overall well-being.

Date :
  1. Date Completed 2019-04-25
  2. Date Revised 2022-04-10
Further Info :

Pubmed ID

30122356

DOI: Digital Object Identifier

NIHMS1055410

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.